Quality assessment of economic analyses in pediatric urology
- PMID: 23374775
- PMCID: PMC3594685
- DOI: 10.1016/j.urology.2012.08.071
Quality assessment of economic analyses in pediatric urology
Abstract
Objective: To describe and evaluate economic analyses or economic evaluations in pediatric urologic literature, including study types such as cost-effectiveness analysis, which are increasingly common in the medical literature.
Methods: We performed a systematic literature review of the MEDLINE, EMBASE, and Cochrane databases (1990-2011) to identify economic analyses of pediatric urologic topics. Studies were evaluated using published quality metrics. We examined the analysis type, data sources, perspective, methodology, sensitivity analyses, and the reporting of methods, results, limitations, and conclusions.
Results: We identified 2945 nonduplicated studies, 60 of which met inclusion criteria. Economic analyses of pediatric urologic topics increased in number during the study period, from 1 study (2%) in 1990 to 7 (12%) in 2010 (P <.0001 for trend). The most common types of analyses were cost-effectiveness and cost-minimization (22 each, 37%), typically performed from the payer perspective (26 [43%]). Although 44 (73%) correctly identified the analysis type, only 21 (35%) correctly identified the study perspective. Optimal data sources were used in 7 studies (11%). Appropriate inflationary discounting was used in 17 of 53 (32%). Sensitivity analyses were not reported in 31 of 53 (58%). The descriptions of study methods were adequate in 43 studies (72%), assumptions were adequately reported in 42 (70%), and 37 (62%) adequately discussed limitations.
Conclusion: Although economic analyses are increasing in the pediatric urologic literature, there is a need for standardization in methods and reporting. Future investigations should attempt to follow standardized reporting guidelines and should pay particular attention to reporting of methods and results, including a comprehensive discussion of limitations.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures


Comment in
-
Editorial comment.Urology. 2013 Feb;81(2):267-8; discussion 268. doi: 10.1016/j.urology.2012.08.099. Urology. 2013. PMID: 23374776 No abstract available.
-
Re: Quality assessment of economic analyses in pediatric urology.J Urol. 2013 Oct;190(4):1377-8. doi: 10.1016/j.juro.2013.06.093. Epub 2013 Jul 3. J Urol. 2013. PMID: 24029356 No abstract available.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Health Technol Assess. 2015. PMID: 25980984 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.Health Technol Assess. 2012 May;16(28):1-130. doi: 10.3310/hta16280. Health Technol Assess. 2012. PMID: 22642789 Free PMC article.
Cited by
-
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.Appl Health Econ Health Policy. 2019 Oct;17(5):577-590. doi: 10.1007/s40258-019-00481-8. Appl Health Econ Health Policy. 2019. PMID: 31098947 Free PMC article.
References
-
- Gold MR, Siegel JE, Russell LB, et al., editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
-
- Chiou CF, Hay JW, Wallace JF, et al. Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003;41(1):32–44. - PubMed
-
- Ungar WJ, Santos MT. The Pediatric Quality Appraisal Questionnaire: an instrument for evaluation of the pediatric health economics literature. Value Health. 2003;6(5):584–594. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous